Effect of Aging on Haemostasis Parameters

Identifying Morphological and Biological Biomarkers of the Venous Thromboembolic Risk Risk Related to Aging

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00299624

Enrollment

100

Registered

2006-03-07

Start date

2005-10-31

Completion date

2006-08-31

Last updated

2010-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging

Keywords

venous thromboembolism risk,, elderly,, hypercoagulability, fibrinolysis, microparticles

Brief summary

Aging is an independent risk factor, without any clear explanation. The primary aim of the study is to depict the effect of aging on the coagulation fibrinolysis parameters and microparticles.

Detailed description

Patients older than 40, without any acute disease and not receiving any antiaggregant and anticoagulant therapy will be included in the study. Blood tests will be performed for coagulation, fibrinolysis and microparticles measurement.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

40 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* age \<40 2 groups : 1 : no history of VTE 2 : history of VTE

Exclusion criteria

* antiaggregant or anticoagulant therapy at curative dose * arterial or thrombotic event in the last month

Countries

France

Outcome results